Title | Type | SJR | H index | Total Docs. (2018) | Total Docs. (3years) | Total Refs. (2018) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2018) | %Female (2018) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Current Topics in Medicinal Chemistry | journal | 0.878 Q2 | 133 | 242 | 775 | 22746 | 2415 | 671 | 3.09 | 93.99 | 41.81 | |
2 | CNS and Neurological Disorders - Drug Targets | journal | 0.747 Q2 | 96 | 87 | 433 | 6391 | 937 | 373 | 2.32 | 73.46 | 36.21 | |
3 | Mini-Reviews in Medicinal Chemistry | journal | 0.609 Q2 | 107 | 124 | 419 | 9892 | 1022 | 373 | 2.49 | 79.77 | 37.37 | |
4 | Current Alzheimer Research | journal | 1.145 Q2 | 103 | 134 | 394 | 9083 | 1226 | 359 | 2.98 | 67.78 | 44.53 | |
5 | Current Nanoscience | journal | 0.336 Q3 | 52 | 65 | 285 | 2563 | 407 | 259 | 1.51 | 39.43 | 33.33 | |
6 | Combinatorial Chemistry and High Throughput Screening | journal | 0.367 Q3 | 70 | 95 | 287 | 3519 | 379 | 253 | 1.43 | 37.04 | 38.55 | |
7 | Current Protein and Peptide Science | journal | 0.599 Q2 | 96 | 116 | 296 | 11924 | 552 | 253 | 1.52 | 102.79 | 36.79 | |
8 | Current Neuropharmacology | journal | 1.490 Q1 | 103 | 116 | 280 | 14411 | 1277 | 246 | 4.05 | 124.23 | 40.18 | |
9 | Current Cancer Drug Targets | journal | 0.875 Q2 | 103 | 87 | 227 | 8117 | 521 | 202 | 2.15 | 93.30 | 41.22 | |
10 | Current Vascular Pharmacology | journal | 0.605 Q2 | 69 | 106 | 251 | 7332 | 481 | 202 | 1.90 | 69.17 | 32.95 | |
11 | Current Stem Cell Research and Therapy | journal | 0.595 Q2 | 63 | 70 | 227 | 6906 | 444 | 199 | 2.08 | 98.66 | 39.50 | |
12 | Current Diabetes Reviews | journal | 0.733 Q2 | 68 | 59 | 156 | 4300 | 350 | 139 | 2.16 | 72.88 | 44.30 | |
13 | Current Medical Imaging | journal | 0.153 Q4 | 37 | 120 | 139 | 4056 | 79 | 136 | 0.50 | 33.80 | 33.70 | |
14 | Current Neurovascular Research | journal | 0.625 | 60 | 47 | 146 | 2068 | 281 | 133 | 1.64 | 44.00 | 41.80 | |
15 | Current Genomics | journal | 0.765 Q3 | 77 | 65 | 153 | 6155 | 367 | 132 | 2.06 | 94.69 | 48.26 | |
16 | Current Gene Therapy | journal | 1.008 Q2 | 80 | 41 | 139 | 3484 | 338 | 128 | 2.16 | 84.98 | 42.50 | |
17 | Current Drug Safety | journal | 0.371 Q3 | 41 | 40 | 131 | 1071 | 158 | 120 | 1.27 | 26.78 | 41.88 | |
18 | Reviews on Recent Clinical Trials | journal | 0.427 Q3 | 35 | 44 | 135 | 2311 | 131 | 120 | 1.00 | 52.52 | 38.38 | |
19 | Current Nutrition and Food Science | journal | 0.192 Q4 | 32 | 53 | 127 | 2600 | 75 | 117 | 0.70 | 49.06 | 47.76 | |
20 | Endocrine, Metabolic and Immune Disorders - Drug Targets | journal | 0.656 Q3 | 63 | 79 | 125 | 4874 | 255 | 117 | 1.28 | 61.70 | 50.13 | |
21 | Current Cardiology Reviews | journal | 0.516 Q2 | 58 | 39 | 126 | 2319 | 218 | 114 | 1.29 | 59.46 | 25.23 | |
22 | Current Respiratory Medicine Reviews | journal | 0.143 Q4 | 15 | 34 | 131 | 1696 | 29 | 108 | 0.21 | 49.88 | 27.50 | |
23 | Current Reviews in Clinical and Experimental Pharmacology | journal | 49 | 30 | 111 | 1656 | 166 | 100 | 1.22 | 55.20 | 30.36 | ||
24 | Current Aging Science | journal | 0.476 Q3 | 42 | 32 | 109 | 1679 | 152 | 98 | 1.35 | 52.47 | 44.85 | |
25 | Current Computer-Aided Drug Design | journal | 0.265 Q3 | 32 | 38 | 113 | 1534 | 109 | 95 | 1.03 | 40.37 | 31.20 | |
26 | Current Pediatric Reviews | journal | 0.216 Q3 | 33 | 35 | 99 | 2055 | 112 | 82 | 1.16 | 58.71 | 65.12 | |
27 | Recent Patents on Anti-Cancer Drug Discovery | journal | 0.529 Q2 | 52 | 33 | 88 | 3586 | 192 | 82 | 2.10 | 108.67 | 50.97 | |
28 | Current Rheumatology Reviews | journal | 0.530 Q3 | 29 | 42 | 82 | 1863 | 180 | 79 | 1.66 | 44.36 | 47.47 | |
29 | Journal of Biology and Today's World (discontinued) | journal | 0.168 Q3 | 8 | 0 | 76 | 0 | 38 | 75 | 0.50 | 0.00 | 0.00 | |
30 | Current Radiopharmaceuticals | journal | 0.299 Q3 | 32 | 31 | 81 | 1232 | 69 | 74 | 0.78 | 39.74 | 41.84 | |
31 | Infectious Disorders - Drug Targets | journal | 0.351 Q3 | 61 | 34 | 83 | 1174 | 85 | 74 | 0.87 | 34.53 | 38.65 | |
32 | Open Biomedical Engineering Journal | journal | 0.201 Q3 | 28 | 9 | 76 | 222 | 82 | 73 | 1.25 | 24.67 | 44.12 | |
33 | Open Cardiovascular Medicine Journal | journal | 0.411 Q3 | 32 | 10 | 74 | 384 | 100 | 72 | 1.23 | 38.40 | 35.19 | |
34 | Recent Advances in Drug Delivery and Formulation | journal | 41 | 16 | 73 | 938 | 55 | 69 | 0.64 | 58.63 | 48.15 | ||
35 | Current Hypertension Reviews | journal | 27 | 22 | 79 | 989 | 126 | 67 | 1.47 | 44.95 | 38.37 | ||
36 | Clinical Practice and Epidemiology in Mental Health | journal | 0.528 Q2 | 58 | 33 | 67 | 1467 | 129 | 66 | 1.70 | 44.45 | 41.73 | |
37 | MicroRNA (Shariqah, United Arab Emirates) | journal | 0.520 Q2 | 29 | 26 | 67 | 0 | 111 | 66 | 1.44 | 0.00 | 30.43 | |
38 | Drug Metabolism Letters | journal | 0.312 Q3 | 31 | 20 | 74 | 622 | 64 | 65 | 0.88 | 31.10 | 46.05 | |
39 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.293 Q3 | 45 | 31 | 66 | 1834 | 76 | 61 | 1.00 | 59.16 | 20.24 | |
40 | Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry | journal | 0.284 Q3 | 27 | 12 | 63 | 452 | 63 | 56 | 0.88 | 37.67 | 39.53 | |
41 | Current Women's Health Reviews | journal | 0.127 Q4 | 16 | 36 | 63 | 2521 | 7 | 56 | 0.10 | 70.03 | 63.38 | |
42 | Recent Advances in Anti-Infective Drug Discovery | journal | 38 | 24 | 68 | 1462 | 74 | 55 | 0.96 | 60.92 | 31.87 | ||
43 | Open AIDS Journal | journal | 1.235 Q1 | 22 | 18 | 58 | 754 | 141 | 54 | 3.03 | 41.89 | 45.95 | |
44 | Anti-Infective Agents | journal | 0.144 Q4 | 26 | 20 | 60 | 906 | 41 | 52 | 0.61 | 45.30 | 36.11 | |
45 | Cardiovascular and Hematological Agents in Medicinal Chemistry | journal | 0.307 Q3 | 43 | 24 | 61 | 1300 | 55 | 52 | 1.03 | 54.17 | 26.67 | |
46 | Current Cancer Therapy Reviews | journal | 0.140 Q4 | 17 | 15 | 63 | 860 | 12 | 52 | 0.22 | 57.33 | 50.00 | |
47 | Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry | journal | 0.123 Q4 | 17 | 10 | 59 | 566 | 14 | 52 | 0.15 | 56.60 | 28.57 | |
48 | Current Drug Therapy | journal | 0.138 Q4 | 20 | 14 | 56 | 678 | 24 | 51 | 0.53 | 48.43 | 26.19 | |
49 | Current Pharmacogenomics and Personalized Medicine | journal | 0.112 Q4 | 20 | 21 | 56 | 1270 | 6 | 50 | 0.16 | 60.48 | 33.96 | |
50 | Current Signal Transduction Therapy | journal | 0.138 Q4 | 22 | 20 | 54 | 961 | 21 | 49 | 0.66 | 48.05 | 33.33 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®